COLLECTION OF PLURIPOTENTIAL HEMATOPOIETIC STEM-CELLS BY CYTAPHERESIS

  • 1 January 1982
    • journal article
    • research article
    • Vol. 59  (4) , 822-827
Abstract
Successful complete hematopoietic reconstitution (CHR) using nonleukemic peripheral stem cells (PSC) after marrow ablation was reported in animals but not man. Previous studies of cytapheresis products from humans, as a prelude to use for CHR, have documented the presence of committed myeloid and erythroid precursors. Mononuclear cell (MNC) products collected on the Fenwal CS3000 blood cell separator were examined for these plus the more primitive mixed (granulo-, erythro-, mono- and megakaryocytic) cell colony-forming units (CFU-GEMM) and for various lymphocytic subpopulations (LSP). One to 2 h products contained 36 .+-. 7 CFU-GEMM/106 MNC (mean .+-. SE, n = 8) or 490 .+-. 131/ml product. This compared favorably with blood (23 .+-. .4/106 MNC or 46 .+-. 8/ml, n = 14) and bone marrow (146 .+-. 58/106 MNC, n = 12). Collection efficiency for E[erythrocyte]-rosette-positive cells approximated that for total lymphocytes and was variable for other LSP. Recovery of CFU-GEMM after freezing in 10% dimethylsulfoxide at a controlled rate and storage in liquid N2 was 54% .+-. 8% (n = 8). Cytapheresis collection of large numbers of pluripotent hematopoietic precursors and demonstration of adequate recovery of these after cryopreservation, both previously unreported, are significant steps toward eventual CHR using nonleukemic PSC.

This publication has 10 references indexed in Scilit: